Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer
US7939271B2 · kind B2 · utility
2Cited by
9References
57Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2008 |
| Grant date | May 10, 2011 |
| Priority date | — |
| Expiry date | Aug 11, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/535
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to prostate cancer markers, compositions comprising such markers, immunoglobulins specific for such markers, and methods of using such markers and/or immunoglobulins to assess an immune response against prostate cancer. An immune response against the markers correlates with an immune response, in particular a humoral immune response, against prostate cancer cells which immune response is preferably associated with prophylaxis of prostate cancer, treatment of prostate cancer, and/or amelioration of at least one symptom associated with prostate cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.